Ace the CPHON Challenge 2025 – Elevate Your Pediatric Oncology Nursing Game!

Folic acid supplementation is essential in the treatment of autoimmune hemolytic anemia (AIHA) because it supports red blood cell production. In AIHA, the body experiences an increased rate of red blood cell destruction, which can lead to a compensatory increase in red blood cell production by the bone marrow. Folic acid, a B-vitamin, is vital for the synthesis of DNA and the production of new cells, including red blood cells. When supplementation is provided, it can help meet the heightened demand for new red blood cells that occurs due to their increased destruction in AIHA, effectively supporting the patient's recovery and management of the condition.

Other options, while relevant in different contexts, do not accurately describe the primary function of folic acid in the treatment of AIHA. For example, folic acid does not directly increase the lifespan of red blood cells, prevent autoimmune reactions, or act as an anti-inflammatory agent in this specific scenario. The key role remains its support of red blood cell production amidst the challenges presented by AIHA.